23.03
price up icon1.14%   0.26
after-market Dopo l'orario di chiusura: 23.20 0.17 +0.74%
loading
Precedente Chiudi:
$22.77
Aprire:
$23.17
Volume 24 ore:
388.46K
Relative Volume:
0.34
Capitalizzazione di mercato:
$1.48B
Reddito:
$193.35M
Utile/perdita netta:
$-177.58M
Rapporto P/E:
-9.40
EPS:
-2.45
Flusso di cassa netto:
$-172.43M
1 W Prestazione:
+8.38%
1M Prestazione:
+13.17%
6M Prestazione:
-5.65%
1 anno Prestazione:
+1.59%
Intervallo 1D:
Value
$23.00
$23.39
Intervallo di 1 settimana:
Value
$21.30
$23.75
Portata 52W:
Value
$16.60
$28.47

Schrodinger Inc Stock (SDGR) Company Profile

Name
Nome
Schrodinger Inc
Name
Telefono
503-299-1150
Name
Indirizzo
1540 BROADWAY, NEW YORK, NY
Name
Dipendente
787
Name
Cinguettio
@schrodinger
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
SDGR's Discussions on Twitter

Confronta SDGR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
SDGR
Schrodinger Inc
23.03 1.67B 193.35M -177.58M -172.43M -2.45
Health Information Services icon
VEEV
Veeva Systems Inc
286.01 46.61B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
64.86 10.57B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
96.91 8.42B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
61.00 11.13B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
WAY
Waystar Holding Corp
36.96 6.33B 906.14M -52.62M 89.62M -0.3621

Schrodinger Inc Stock (SDGR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-03 Ripresa Morgan Stanley Equal-Weight
2024-07-02 Iniziato Leerink Partners Outperform
2023-12-05 Iniziato KeyBanc Capital Markets Overweight
2023-05-05 Ripresa Piper Sandler Overweight
2022-12-19 Iniziato Goldman Neutral
2022-03-01 Iniziato Citigroup Buy
2021-11-19 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-11-19 Iniziato Piper Sandler Overweight
2021-11-11 Downgrade BofA Securities Buy → Neutral
2021-10-13 Iniziato Berenberg Buy
2021-09-01 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2021-05-25 Iniziato Craig Hallum Buy
2020-11-23 Aggiornamento BofA Securities Neutral → Buy
2020-10-12 Aggiornamento Jefferies Hold → Buy
2020-03-02 Iniziato BMO Capital Markets Outperform
2020-03-02 Iniziato Jefferies Hold
2020-03-02 Iniziato Morgan Stanley Equal-Weight
Mostra tutto

Schrodinger Inc Borsa (SDGR) Ultime notizie

pulisher
Jul 23, 2025

Is Schrödinger Inc. a good long term investmentPowerful market insights - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Schrodinger, Inc. (SDGR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Schrödinger Inc. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Schrödinger Inc. stock priceTremendous gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Schrödinger Inc. stockSuperior stock growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 18, 2025

Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

When the Price of (SDGR) Talks, People Listen - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 18, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Ajax Therapeutics and Schrödinger expand JAK inhibitor collaboration By Investing.com - Investing.com Nigeria

Jul 17, 2025
pulisher
Jul 17, 2025

Schrodinger stock maintains Buy rating at Citi on Ajax collaboration By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Schrodinger stock maintains Buy rating at Citi on Ajax collaboration - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Ajax Therapeutics and Schrödinger expand JAK inhibitor collaboration - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target - Business Wire

Jul 17, 2025
pulisher
Jul 16, 2025

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - Barchart.com

Jul 16, 2025
pulisher
Jul 14, 2025

What makes Schrödinger Inc. stock price move sharplyMoney Making Low Risk Plans - beatles.ru

Jul 14, 2025
pulisher
Jul 12, 2025

Morgan Stanley Assumes Coverage on Schrödinger (SDGR) Stock - MSN

Jul 12, 2025
pulisher
Jul 10, 2025

BMO Capital Remains a Buy on Schrodinger (SDGR) - The Globe and Mail

Jul 10, 2025
pulisher
Jul 07, 2025

(SDGR) On The My Stocks Page - news.stocktradersdaily.com

Jul 07, 2025
pulisher
Jul 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc.SDGR - FinancialContent

Jul 06, 2025
pulisher
Jul 04, 2025

Schrödinger (SDGR) Receives FDA Fast Track Designation for Cancer Drug SGR-1505 - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Schrodinger stock rating assumed by Morgan Stanley at Equalweight - Investing.com India

Jul 03, 2025
pulisher
Jul 01, 2025

Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report - ReportAlert

Jul 01, 2025
pulisher
Jun 29, 2025

Schrödinger gets Fast Track status for SGR-1505 - MSN

Jun 29, 2025
pulisher
Jun 27, 2025

Schrödinger (SDGR) Gains FDA Fast Track for MALT1 Inhibitor - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia | SDGR Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Schrödinger gets Fast Track status for SGR-1505 (SDGR:NASDAQ) - Seeking Alpha

Jun 27, 2025
pulisher
Jun 18, 2025

Schrodinger Announces Board Elections and Approvals - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 17, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | PRN_FinancialWrapper | PR Newswire - FinancialContent

Jun 17, 2025
pulisher
Jun 16, 2025

Where are the Opportunities in (SDGR) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 15, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, ... - Eagle-Tribune

Jun 15, 2025
pulisher
Jun 15, 2025

Harbor Capital Advisors Inc. Grows Stake in Schrödinger, Inc. (NASDAQ:SDGR) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Schrödinger slides after early-stage trial data for cancer therapy - MSN

Jun 14, 2025

Schrodinger Inc Azioni (SDGR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$10.80
price up icon 1.69%
$21.39
price up icon 1.33%
$20.30
price up icon 1.15%
$47.05
price up icon 0.79%
$21.30
price up icon 5.71%
health_information_services WAY
$36.96
price up icon 1.07%
Capitalizzazione:     |  Volume (24 ore):